Molecular mechanisms of HIV type 1 prophylaxis failure revealed by single-genome sequencing

J Infect Dis. 2013 Nov 15;208(10):1598-603. doi: 10.1093/infdis/jit485. Epub 2013 Sep 9.

Abstract

Trials of human immunodeficiency virus type 1 (HIV) pre- and postexposure prophylaxis show promise. Here, we describe a novel strategy for deciphering mechanisms of prophylaxis failure that could improve therapeutic outcomes. A healthcare worker began antiretroviral prophylaxis immediately after a high-risk needlestick injury but nonetheless became viremic 11 weeks later. Single-genome sequencing of plasma viral RNA identified 15 drug susceptible transmitted/founder HIV genomes responsible for productive infection. Sequences emanating from these genomes exhibited extremely low diversity, suggesting virus sequestration as opposed to low-level replication as the cause of breakthrough infection. Identification of transmitted/founder viruses allows for genome-wide assessment of molecular mechanisms of prophylaxis failure.

Keywords: HIV-1 transmission; multiple virus transmission; occupational exposure; post-exposure prophylaxis; single genome sequencing; virus sequestration.

Publication types

  • Case Reports
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Drug Resistance, Viral / genetics
  • Female
  • Genome, Viral*
  • HIV Infections / diagnosis
  • HIV Infections / drug therapy*
  • HIV Infections / prevention & control
  • HIV-1 / classification
  • HIV-1 / drug effects*
  • HIV-1 / genetics*
  • Humans
  • Middle Aged
  • Mutation
  • Phylogeny
  • Premedication*
  • RNA, Viral
  • Sequence Analysis, DNA
  • Treatment Failure

Substances

  • Anti-HIV Agents
  • RNA, Viral